Tag Archives: Treatment

FDA Approves Bylvay (odevixibat) for the Treatment of Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis (PFIC)

FDA Approves Bylvay (odevixibat) for the Treatment of Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis (PFIC) BOSTON, July 20, 2021 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators, today announced U.S. Food & Drug Administration (FDA) approval of Bylvay (odevixibat), the first drug approved for the treatment of pruritus in… Read More »

Battery-Free Wireless Pacemaker Dissolves Post Treatment

Researchers at Northwestern University and collaborators have developed a temporary cardiac pacemaker that dissolves away in the body into harmless byproducts. The technology avoids the need for leads penetrating the skin as well as follow-up procedures to remove a pacemaker. The device could make temporary pacemaker placement a safer and more convenient experience for patients.… Read More »

FDA Approves Tembexa (brincidofovir) for the Treatment of Smallpox

FDA Approves Tembexa (brincidofovir) for the Treatment of Smallpox DURHAM, N.C., June 04, 2021 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Tembexa (brincidofovir) tablets and oral suspension approval… Read More »

Dolutegravir superior to standard-of-care treatment in children and adolescents

Dolutegravir-based treatment was superior to treatment based on efavirenz or a boosted protease inhibitor in children and adolescents, both as first-line or second-line treatment, a large international study has concluded. Dr Anna Turkova of the United Kingdom Medical Research Council presented the 96-week results of the ODYSSEY study at the 2021 virtual Conference on Retroviruses… Read More »

The Buenos Aires patient: Argentinian woman controls HIV for at least 12 years after stopping treatment

An Argentinian woman, now in her 50s, has controlled HIV below the limits of detection since stopping HIV treatment due to side-effects in 2007, researchers from Buenos Aires and the US National Institutes of Health report. The woman no longer has antibodies to HIV and researchers found only a small number of cells containing HIV… Read More »